When you talk about medical drugs, consumers tend to fixate on their effectiveness and price. Rarely do they consider the long drawn out process that any new drug has to meet before making the journey from the laboratory to the pharmacies or hospitals.
The Malaysian government has committed funding to improve the healthcare systems in order to further support clinical research. Clinical Research Malaysia (CRM) is a non-profit organisation – wholly owned by the government of Malaysia, which intends to develop infrastructure for the Clinical Research Centre networks, and be able to support global industry sponsored research (ISR) requirements. Recently, CRM appointed a new CEO, Dr Akhmal Yusof, who held individual meetings
Do you have any queries?